Related references
Note: Only part of the references are listed.Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase
Michael E. Prime et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
VX680 Binding in Aurora A: π-π Interactions Involving the Conserved Aromatic Amino Acid of the Flexible Glycine-Rich Loop
Taiana M. Oliveira et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2011)
Cancer driver mutations in protein kinase genes
Ali Torkamani et al.
CANCER LETTERS (2009)
Fragment-Based Discovery of Inhibitors of Protein Kinase B
Thomas G. Davies et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
Zhong-Zhe Lin et al.
JOURNAL OF HEPATOLOGY (2009)
Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agents
John R. Pollard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Comparative surface geometry of the protein kinase family
Elaine E. Thompson et al.
PROTEIN SCIENCE (2009)
Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration
John J. Caldwell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
A helix scaffold for the assembly of active protein kinases
Alexandr P. Kornev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Modulation of kinase-inhibitor interactions by auxiliary protein binding: Crystallography studies on Aurora A interactions with VX-680 and with TPX2
Baoguang Zhao et al.
PROTEIN SCIENCE (2008)
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Structural basis for potent inhibition of the Aurora kinases and a T3151 multi-drug resistant mutant form of Abl kinase by VX-680
G. M. T. Cheetham et al.
CANCER LETTERS (2007)
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
Thomas G. Davies et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitors
Leslie W. Tari et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificity
Stefan Bonn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library
Q Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the aurora kinase inhibitor VX-680
MA Young et al.
CANCER RESEARCH (2006)
Crystal structure of the E230Q mutant of cAMP-dependent protein kinase reveals an unexpected apoenzyme conformation and an extended N-terminal A helix
J Wu et al.
PROTEIN SCIENCE (2005)
The in vitro and in vivo effects of JNJ-7706621:: A dual inhibitor of cyclin-dependent kinases and aurora kinases
S Emanuel et al.
CANCER RESEARCH (2005)
Aurora kinases
VM Bolanos-Garcia
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Structural bioinformatics-based design of selective, irreversible kinase inhibitors
MS Cohen et al.
SCIENCE (2005)
Protein production by auto-induction in high-density shaking cultures
FW Studier
PROTEIN EXPRESSION AND PURIFICATION (2005)
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EA Harrington et al.
NATURE MEDICINE (2004)
Crystal structure of a cAMP-dependent protein kinase mutant at 1.26 Å:: New insights into the catalytic mechanism
J Yang et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells
K Sasai et al.
CELL MOTILITY AND THE CYTOSKELETON (2004)
The typically disordered n-terminus of PKA can fold as a helix and project the myristoylation site into solution
C Breitenlechner et al.
BIOCHEMISTRY (2004)
Mutants of protein kinase a that mimic the ATP-binding site of protein kinase B (AKT)
M Gassel et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Phosphorylation and flexibility of cyclic-AMP-dependent protein kinase (PKA) using 31P NMR Spectroscopy
MHJ Seifert et al.
BIOCHEMISTRY (2002)
Specificity and mechanism of action of some commonly used protein kinase inhibitors
SP Davies et al.
BIOCHEMICAL JOURNAL (2000)
Intracellular distribution of mammalian protein kinase A catalytic subunit altered by conserved Asn2 deamidation
R Pepperkok et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
